Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
New research in the area of breast cancer detailed
September 8th, 2005
Investigators in the United Kingdom and Japan have published new breast cancer data. Study 1: Loss of E-cadherin expression predicts poor outcome in breast carcinoma patients with non-lobular tumors. "E-cadherin is a cell adhesion molecule that is expressed in normal breast tissue and is often considered useful as a phenotypic marker in breast cancer diagnosis, with absence of its expression frequently observed in tumors of lobular subtype," pathologists in England explained. "However, the clinicopathological and prognostic value of E-cadherin in the more frequent non-lobular types of breast carcinoma is unclear." In a study...
Source: Women's Health Weekly (2005-09-08)
|
